Pal-ing, Jeneva M.
HRN: 26-79-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2025
CEFTRIAXONE 1G (VIAL)
03/15/2025
03/23/2025
IV
2gms
Od
None
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes